U.S. Markets open in 4 hrs 55 mins
S&P Futures
4,160.50+5.00(+0.12%)Dow Futures
33,976.00+18.00(+0.05%)Nasdaq Futures
13,928.75+31.50(+0.23%)
Exicure, Inc. (XCUR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7000-0.1000 (-5.56%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1.8000 |
| Open | 1.8400 |
| Bid | 0.0000 x 2200 |
| Ask | 0.0000 x 1300 |
| Day's Range | 1.6900 - 1.8400 |
| 52 Week Range | 1.3800 - 3.3000 |
| Volume | 434,736 |
| Avg. Volume | 645,868 |
| Market Cap | 149.533M |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2830 |
| Earnings Date | Mar 11, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.00 |
- Business Wire
Spherical Nucleic Acid Technology Shows Promising Results in Phase 0 Trial in Patients With Glioblastoma at Northwestern University
Spherical Nucleic Acid technology shows promising results in phase 0 trial in patients with glioblastoma at Northwestern University.
- Business Wire
Exicure, Inc. Reports Full Year 2020 Financial Results and Corporate Progress
Exicure reported fourth quarter and full year financial results for the year ended December 31, 2020 and provided an update on corporate progress.
- Business Wire
Exicure Announces Appointments of Elizabeth Garofalo, M.D., and Andrew Sassine to Its Board of Directors
Exicure today announced the appointment of Elizabeth (Betsy) Garofalo, M.D. and Mr. Andrew Sassine to its Board of Directors.
© 2021 Verizon Media. All rights reserved.
